nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—ABCC4—Sorafenib—thyroid cancer	0.437	1	CbGbCtD
Oseltamivir—CES1—larynx—thyroid cancer	0.0516	0.304	CbGeAlD
Oseltamivir—NEU1—saliva-secreting gland—thyroid cancer	0.0266	0.156	CbGeAlD
Oseltamivir—NEU1—trachea—thyroid cancer	0.0205	0.121	CbGeAlD
Oseltamivir—NEU1—thyroid gland—thyroid cancer	0.0162	0.0954	CbGeAlD
Oseltamivir—CES1—neck—thyroid cancer	0.0137	0.0806	CbGeAlD
Oseltamivir—NEU1—lymph node—thyroid cancer	0.0101	0.0593	CbGeAlD
Oseltamivir—CES1—thyroid gland—thyroid cancer	0.00652	0.0384	CbGeAlD
Oseltamivir—CES1—head—thyroid cancer	0.00578	0.034	CbGeAlD
Oseltamivir—ABCC4—thyroid gland—thyroid cancer	0.00439	0.0258	CbGeAlD
Oseltamivir—CES1—lymph node—thyroid cancer	0.00405	0.0238	CbGeAlD
Oseltamivir—ABCC4—head—thyroid cancer	0.00389	0.0229	CbGeAlD
Oseltamivir—SLC22A8—head—thyroid cancer	0.00386	0.0227	CbGeAlD
Oseltamivir—Hepatic failure—Sorafenib—thyroid cancer	0.00369	0.00937	CcSEcCtD
Oseltamivir—Conjunctivitis—Vandetanib—thyroid cancer	0.00368	0.00935	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00358	0.0091	CcSEcCtD
Oseltamivir—Epistaxis—Vandetanib—thyroid cancer	0.00357	0.00907	CcSEcCtD
Oseltamivir—Sinusitis—Vandetanib—thyroid cancer	0.00355	0.00903	CcSEcCtD
Oseltamivir—Pain in extremity—Sorafenib—thyroid cancer	0.00331	0.00842	CcSEcCtD
Oseltamivir—Visual impairment—Vandetanib—thyroid cancer	0.00327	0.00832	CcSEcCtD
Oseltamivir—Erythema multiforme—Vandetanib—thyroid cancer	0.00321	0.00817	CcSEcCtD
Oseltamivir—Eye disorder—Vandetanib—thyroid cancer	0.00318	0.00807	CcSEcCtD
Oseltamivir—Cardiac disorder—Vandetanib—thyroid cancer	0.00315	0.00801	CcSEcCtD
Oseltamivir—Mediastinal disorder—Vandetanib—thyroid cancer	0.00306	0.00778	CcSEcCtD
Oseltamivir—Arrhythmia—Vandetanib—thyroid cancer	0.00304	0.00771	CcSEcCtD
Oseltamivir—Abdominal pain upper—Sorafenib—thyroid cancer	0.00303	0.00769	CcSEcCtD
Oseltamivir—Body temperature decreased—Epirubicin—thyroid cancer	0.00301	0.00765	CcSEcCtD
Oseltamivir—Hypothermia—Epirubicin—thyroid cancer	0.00301	0.00765	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00298	0.00758	CcSEcCtD
Oseltamivir—Mental disorder—Vandetanib—thyroid cancer	0.00298	0.00757	CcSEcCtD
Oseltamivir—Nasopharyngitis—Sorafenib—thyroid cancer	0.00296	0.00753	CcSEcCtD
Oseltamivir—Body temperature decreased—Doxorubicin—thyroid cancer	0.00278	0.00708	CcSEcCtD
Oseltamivir—Hypothermia—Doxorubicin—thyroid cancer	0.00278	0.00708	CcSEcCtD
Oseltamivir—ABCC4—lymph node—thyroid cancer	0.00272	0.016	CbGeAlD
Oseltamivir—Cough—Vandetanib—thyroid cancer	0.00258	0.00656	CcSEcCtD
Oseltamivir—Pneumonia—Sorafenib—thyroid cancer	0.00257	0.00653	CcSEcCtD
Oseltamivir—Convulsion—Vandetanib—thyroid cancer	0.00256	0.00651	CcSEcCtD
Oseltamivir—Infestation NOS—Sorafenib—thyroid cancer	0.00255	0.00649	CcSEcCtD
Oseltamivir—Infestation—Sorafenib—thyroid cancer	0.00255	0.00649	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00253	0.00643	CcSEcCtD
Oseltamivir—Arthralgia—Vandetanib—thyroid cancer	0.00252	0.0064	CcSEcCtD
Oseltamivir—Anxiety—Vandetanib—thyroid cancer	0.00251	0.00638	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.0025	0.00636	CcSEcCtD
Oseltamivir—Jaundice—Sorafenib—thyroid cancer	0.00249	0.00633	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00241	0.00614	CcSEcCtD
Oseltamivir—Epistaxis—Sorafenib—thyroid cancer	0.00241	0.00612	CcSEcCtD
Oseltamivir—Infection—Vandetanib—thyroid cancer	0.0024	0.0061	CcSEcCtD
Oseltamivir—Nervous system disorder—Vandetanib—thyroid cancer	0.00237	0.00602	CcSEcCtD
Oseltamivir—Thrombocytopenia—Vandetanib—thyroid cancer	0.00236	0.00601	CcSEcCtD
Oseltamivir—Skin disorder—Vandetanib—thyroid cancer	0.00234	0.00596	CcSEcCtD
Oseltamivir—Dermatitis atopic—Epirubicin—thyroid cancer	0.00228	0.00579	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0022	0.00559	CcSEcCtD
Oseltamivir—Insomnia—Vandetanib—thyroid cancer	0.00218	0.00555	CcSEcCtD
Oseltamivir—Erythema multiforme—Sorafenib—thyroid cancer	0.00217	0.00551	CcSEcCtD
Oseltamivir—Otitis media—Epirubicin—thyroid cancer	0.00217	0.00551	CcSEcCtD
Oseltamivir—Cardiac disorder—Sorafenib—thyroid cancer	0.00213	0.00541	CcSEcCtD
Oseltamivir—Dyspepsia—Vandetanib—thyroid cancer	0.00212	0.0054	CcSEcCtD
Oseltamivir—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00211	0.00536	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00208	0.0053	CcSEcCtD
Oseltamivir—Fatigue—Vandetanib—thyroid cancer	0.00208	0.00529	CcSEcCtD
Oseltamivir—Immune system disorder—Sorafenib—thyroid cancer	0.00207	0.00526	CcSEcCtD
Oseltamivir—Mediastinal disorder—Sorafenib—thyroid cancer	0.00207	0.00525	CcSEcCtD
Oseltamivir—Pain—Vandetanib—thyroid cancer	0.00206	0.00525	CcSEcCtD
Oseltamivir—Arrhythmia—Sorafenib—thyroid cancer	0.00205	0.0052	CcSEcCtD
Oseltamivir—Blood disorder—Epirubicin—thyroid cancer	0.00202	0.00513	CcSEcCtD
Oseltamivir—Mental disorder—Sorafenib—thyroid cancer	0.00201	0.0051	CcSEcCtD
Oseltamivir—Otitis media—Doxorubicin—thyroid cancer	0.002	0.0051	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00197	0.00502	CcSEcCtD
Oseltamivir—Delirium—Epirubicin—thyroid cancer	0.00196	0.00498	CcSEcCtD
Oseltamivir—Body temperature increased—Vandetanib—thyroid cancer	0.00191	0.00485	CcSEcCtD
Oseltamivir—Abdominal pain—Vandetanib—thyroid cancer	0.00191	0.00485	CcSEcCtD
Oseltamivir—Blood disorder—Doxorubicin—thyroid cancer	0.00187	0.00475	CcSEcCtD
Oseltamivir—Bone disorder—Epirubicin—thyroid cancer	0.00187	0.00475	CcSEcCtD
Oseltamivir—Anaemia—Sorafenib—thyroid cancer	0.00184	0.00469	CcSEcCtD
Oseltamivir—Herpes simplex—Epirubicin—thyroid cancer	0.00183	0.00465	CcSEcCtD
Oseltamivir—Angioedema—Sorafenib—thyroid cancer	0.00182	0.00463	CcSEcCtD
Oseltamivir—Delirium—Doxorubicin—thyroid cancer	0.00181	0.00461	CcSEcCtD
Oseltamivir—Cough—Sorafenib—thyroid cancer	0.00174	0.00443	CcSEcCtD
Oseltamivir—Asthenia—Vandetanib—thyroid cancer	0.00173	0.0044	CcSEcCtD
Oseltamivir—Bone disorder—Doxorubicin—thyroid cancer	0.00173	0.00439	CcSEcCtD
Oseltamivir—Myalgia—Sorafenib—thyroid cancer	0.0017	0.00432	CcSEcCtD
Oseltamivir—Arthralgia—Sorafenib—thyroid cancer	0.0017	0.00432	CcSEcCtD
Oseltamivir—Herpes simplex—Doxorubicin—thyroid cancer	0.00169	0.0043	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00169	0.00429	CcSEcCtD
Oseltamivir—Hepatocellular injury—Epirubicin—thyroid cancer	0.00169	0.00429	CcSEcCtD
Oseltamivir—Diarrhoea—Vandetanib—thyroid cancer	0.00165	0.0042	CcSEcCtD
Oseltamivir—Influenza like illness—Epirubicin—thyroid cancer	0.00164	0.00416	CcSEcCtD
Oseltamivir—Anaphylactic shock—Sorafenib—thyroid cancer	0.00163	0.00414	CcSEcCtD
Oseltamivir—Infection—Sorafenib—thyroid cancer	0.00162	0.00411	CcSEcCtD
Oseltamivir—Nervous system disorder—Sorafenib—thyroid cancer	0.0016	0.00406	CcSEcCtD
Oseltamivir—Dizziness—Vandetanib—thyroid cancer	0.0016	0.00406	CcSEcCtD
Oseltamivir—Thrombocytopenia—Sorafenib—thyroid cancer	0.00159	0.00405	CcSEcCtD
Oseltamivir—Skin disorder—Sorafenib—thyroid cancer	0.00158	0.00402	CcSEcCtD
Oseltamivir—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00156	0.00397	CcSEcCtD
Oseltamivir—Vomiting—Vandetanib—thyroid cancer	0.00153	0.0039	CcSEcCtD
Oseltamivir—Rash—Vandetanib—thyroid cancer	0.00152	0.00387	CcSEcCtD
Oseltamivir—Dermatitis—Vandetanib—thyroid cancer	0.00152	0.00386	CcSEcCtD
Oseltamivir—Influenza like illness—Doxorubicin—thyroid cancer	0.00152	0.00385	CcSEcCtD
Oseltamivir—Headache—Vandetanib—thyroid cancer	0.00151	0.00384	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00148	0.00377	CcSEcCtD
Oseltamivir—Lymphadenopathy—Epirubicin—thyroid cancer	0.00144	0.00365	CcSEcCtD
Oseltamivir—Nausea—Vandetanib—thyroid cancer	0.00143	0.00364	CcSEcCtD
Oseltamivir—Dyspepsia—Sorafenib—thyroid cancer	0.00143	0.00364	CcSEcCtD
Oseltamivir—Diabetes mellitus—Epirubicin—thyroid cancer	0.00141	0.00358	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00141	0.00357	CcSEcCtD
Oseltamivir—Fatigue—Sorafenib—thyroid cancer	0.0014	0.00357	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Epirubicin—thyroid cancer	0.0014	0.00356	CcSEcCtD
Oseltamivir—Pain—Sorafenib—thyroid cancer	0.00139	0.00354	CcSEcCtD
Oseltamivir—Eczema—Epirubicin—thyroid cancer	0.00136	0.00346	CcSEcCtD
Oseltamivir—Hepatic failure—Epirubicin—thyroid cancer	0.00136	0.00346	CcSEcCtD
Oseltamivir—Eye pain—Epirubicin—thyroid cancer	0.00136	0.00345	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00133	0.00338	CcSEcCtD
Oseltamivir—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00133	0.00338	CcSEcCtD
Oseltamivir—Diabetes mellitus—Doxorubicin—thyroid cancer	0.0013	0.00331	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.0013	0.00329	CcSEcCtD
Oseltamivir—Urticaria—Sorafenib—thyroid cancer	0.00129	0.00329	CcSEcCtD
Oseltamivir—Abdominal pain—Sorafenib—thyroid cancer	0.00129	0.00327	CcSEcCtD
Oseltamivir—Body temperature increased—Sorafenib—thyroid cancer	0.00129	0.00327	CcSEcCtD
Oseltamivir—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00127	0.00322	CcSEcCtD
Oseltamivir—Eczema—Doxorubicin—thyroid cancer	0.00126	0.0032	CcSEcCtD
Oseltamivir—Hepatic failure—Doxorubicin—thyroid cancer	0.00126	0.0032	CcSEcCtD
Oseltamivir—Eye pain—Doxorubicin—thyroid cancer	0.00125	0.00319	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00122	0.00311	CcSEcCtD
Oseltamivir—Pain in extremity—Epirubicin—thyroid cancer	0.00122	0.00311	CcSEcCtD
Oseltamivir—Hypersensitivity—Sorafenib—thyroid cancer	0.0012	0.00305	CcSEcCtD
Oseltamivir—Face oedema—Epirubicin—thyroid cancer	0.00118	0.003	CcSEcCtD
Oseltamivir—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00117	0.00298	CcSEcCtD
Oseltamivir—Asthenia—Sorafenib—thyroid cancer	0.00117	0.00297	CcSEcCtD
Oseltamivir—Pain in extremity—Doxorubicin—thyroid cancer	0.00113	0.00288	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00113	0.00288	CcSEcCtD
Oseltamivir—Liver function test abnormal—Epirubicin—thyroid cancer	0.00113	0.00287	CcSEcCtD
Oseltamivir—Abdominal pain upper—Epirubicin—thyroid cancer	0.00112	0.00284	CcSEcCtD
Oseltamivir—Diarrhoea—Sorafenib—thyroid cancer	0.00111	0.00283	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.0011	0.0028	CcSEcCtD
Oseltamivir—Nasopharyngitis—Epirubicin—thyroid cancer	0.00109	0.00278	CcSEcCtD
Oseltamivir—Face oedema—Doxorubicin—thyroid cancer	0.00109	0.00278	CcSEcCtD
Oseltamivir—Dizziness—Sorafenib—thyroid cancer	0.00108	0.00274	CcSEcCtD
Oseltamivir—Asthma—Epirubicin—thyroid cancer	0.00106	0.00269	CcSEcCtD
Oseltamivir—Influenza—Epirubicin—thyroid cancer	0.00106	0.00269	CcSEcCtD
Oseltamivir—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00105	0.00266	CcSEcCtD
Oseltamivir—Vomiting—Sorafenib—thyroid cancer	0.00104	0.00263	CcSEcCtD
Oseltamivir—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00103	0.00263	CcSEcCtD
Oseltamivir—Angina pectoris—Epirubicin—thyroid cancer	0.00103	0.00262	CcSEcCtD
Oseltamivir—Rash—Sorafenib—thyroid cancer	0.00103	0.00261	CcSEcCtD
Oseltamivir—Dermatitis—Sorafenib—thyroid cancer	0.00103	0.00261	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00102	0.00259	CcSEcCtD
Oseltamivir—Headache—Sorafenib—thyroid cancer	0.00102	0.00259	CcSEcCtD
Oseltamivir—Bronchitis—Epirubicin—thyroid cancer	0.00102	0.00259	CcSEcCtD
Oseltamivir—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00101	0.00257	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000984	0.0025	CcSEcCtD
Oseltamivir—Asthma—Doxorubicin—thyroid cancer	0.000979	0.00249	CcSEcCtD
Oseltamivir—Influenza—Doxorubicin—thyroid cancer	0.000979	0.00249	CcSEcCtD
Oseltamivir—Nausea—Sorafenib—thyroid cancer	0.000967	0.00246	CcSEcCtD
Oseltamivir—Angina pectoris—Doxorubicin—thyroid cancer	0.000954	0.00242	CcSEcCtD
Oseltamivir—Pneumonia—Epirubicin—thyroid cancer	0.000949	0.00241	CcSEcCtD
Oseltamivir—Infestation NOS—Epirubicin—thyroid cancer	0.000944	0.0024	CcSEcCtD
Oseltamivir—Infestation—Epirubicin—thyroid cancer	0.000944	0.0024	CcSEcCtD
Oseltamivir—Bronchitis—Doxorubicin—thyroid cancer	0.000942	0.00239	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000935	0.00238	CcSEcCtD
Oseltamivir—Jaundice—Epirubicin—thyroid cancer	0.00092	0.00234	CcSEcCtD
Oseltamivir—Conjunctivitis—Epirubicin—thyroid cancer	0.000917	0.00233	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00091	0.00231	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000892	0.00227	CcSEcCtD
Oseltamivir—Epistaxis—Epirubicin—thyroid cancer	0.00089	0.00226	CcSEcCtD
Oseltamivir—Sinusitis—Epirubicin—thyroid cancer	0.000885	0.00225	CcSEcCtD
Oseltamivir—Pneumonia—Doxorubicin—thyroid cancer	0.000878	0.00223	CcSEcCtD
Oseltamivir—Infestation—Doxorubicin—thyroid cancer	0.000873	0.00222	CcSEcCtD
Oseltamivir—Infestation NOS—Doxorubicin—thyroid cancer	0.000873	0.00222	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000866	0.0022	CcSEcCtD
Oseltamivir—Jaundice—Doxorubicin—thyroid cancer	0.000851	0.00216	CcSEcCtD
Oseltamivir—Conjunctivitis—Doxorubicin—thyroid cancer	0.000849	0.00216	CcSEcCtD
Oseltamivir—Hepatitis—Epirubicin—thyroid cancer	0.000847	0.00215	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000826	0.0021	CcSEcCtD
Oseltamivir—Epistaxis—Doxorubicin—thyroid cancer	0.000824	0.00209	CcSEcCtD
Oseltamivir—Sinusitis—Doxorubicin—thyroid cancer	0.000819	0.00208	CcSEcCtD
Oseltamivir—Visual impairment—Epirubicin—thyroid cancer	0.000816	0.00207	CcSEcCtD
Oseltamivir—Erythema multiforme—Epirubicin—thyroid cancer	0.000801	0.00204	CcSEcCtD
Oseltamivir—Eye disorder—Epirubicin—thyroid cancer	0.000792	0.00201	CcSEcCtD
Oseltamivir—Cardiac disorder—Epirubicin—thyroid cancer	0.000786	0.002	CcSEcCtD
Oseltamivir—Hepatitis—Doxorubicin—thyroid cancer	0.000784	0.00199	CcSEcCtD
Oseltamivir—Immune system disorder—Epirubicin—thyroid cancer	0.000765	0.00194	CcSEcCtD
Oseltamivir—Mediastinal disorder—Epirubicin—thyroid cancer	0.000763	0.00194	CcSEcCtD
Oseltamivir—Arrhythmia—Epirubicin—thyroid cancer	0.000757	0.00192	CcSEcCtD
Oseltamivir—Visual impairment—Doxorubicin—thyroid cancer	0.000755	0.00192	CcSEcCtD
Oseltamivir—Mental disorder—Epirubicin—thyroid cancer	0.000742	0.00189	CcSEcCtD
Oseltamivir—Erythema multiforme—Doxorubicin—thyroid cancer	0.000741	0.00188	CcSEcCtD
Oseltamivir—Eye disorder—Doxorubicin—thyroid cancer	0.000732	0.00186	CcSEcCtD
Oseltamivir—Cardiac disorder—Doxorubicin—thyroid cancer	0.000727	0.00185	CcSEcCtD
Oseltamivir—Back pain—Epirubicin—thyroid cancer	0.000713	0.00181	CcSEcCtD
Oseltamivir—Immune system disorder—Doxorubicin—thyroid cancer	0.000708	0.0018	CcSEcCtD
Oseltamivir—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000706	0.0018	CcSEcCtD
Oseltamivir—Arrhythmia—Doxorubicin—thyroid cancer	0.0007	0.00178	CcSEcCtD
Oseltamivir—Mental disorder—Doxorubicin—thyroid cancer	0.000687	0.00175	CcSEcCtD
Oseltamivir—Anaemia—Epirubicin—thyroid cancer	0.000682	0.00173	CcSEcCtD
Oseltamivir—Agitation—Epirubicin—thyroid cancer	0.000678	0.00172	CcSEcCtD
Oseltamivir—Vertigo—Epirubicin—thyroid cancer	0.000662	0.00168	CcSEcCtD
Oseltamivir—Back pain—Doxorubicin—thyroid cancer	0.00066	0.00168	CcSEcCtD
Oseltamivir—Cough—Epirubicin—thyroid cancer	0.000643	0.00164	CcSEcCtD
Oseltamivir—Convulsion—Epirubicin—thyroid cancer	0.000639	0.00162	CcSEcCtD
Oseltamivir—Anaemia—Doxorubicin—thyroid cancer	0.000631	0.0016	CcSEcCtD
Oseltamivir—Arthralgia—Epirubicin—thyroid cancer	0.000628	0.0016	CcSEcCtD
Oseltamivir—Myalgia—Epirubicin—thyroid cancer	0.000628	0.0016	CcSEcCtD
Oseltamivir—Agitation—Doxorubicin—thyroid cancer	0.000627	0.00159	CcSEcCtD
Oseltamivir—Anxiety—Epirubicin—thyroid cancer	0.000626	0.00159	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000623	0.00158	CcSEcCtD
Oseltamivir—Vertigo—Doxorubicin—thyroid cancer	0.000613	0.00156	CcSEcCtD
Oseltamivir—Confusional state—Epirubicin—thyroid cancer	0.000607	0.00154	CcSEcCtD
Oseltamivir—Anaphylactic shock—Epirubicin—thyroid cancer	0.000602	0.00153	CcSEcCtD
Oseltamivir—Infection—Epirubicin—thyroid cancer	0.000598	0.00152	CcSEcCtD
Oseltamivir—Cough—Doxorubicin—thyroid cancer	0.000595	0.00151	CcSEcCtD
Oseltamivir—Convulsion—Doxorubicin—thyroid cancer	0.000591	0.0015	CcSEcCtD
Oseltamivir—Nervous system disorder—Epirubicin—thyroid cancer	0.00059	0.0015	CcSEcCtD
Oseltamivir—Thrombocytopenia—Epirubicin—thyroid cancer	0.000589	0.0015	CcSEcCtD
Oseltamivir—Skin disorder—Epirubicin—thyroid cancer	0.000585	0.00149	CcSEcCtD
Oseltamivir—Myalgia—Doxorubicin—thyroid cancer	0.000581	0.00148	CcSEcCtD
Oseltamivir—Arthralgia—Doxorubicin—thyroid cancer	0.000581	0.00148	CcSEcCtD
Oseltamivir—Anxiety—Doxorubicin—thyroid cancer	0.000579	0.00147	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000577	0.00147	CcSEcCtD
Oseltamivir—Confusional state—Doxorubicin—thyroid cancer	0.000561	0.00143	CcSEcCtD
Oseltamivir—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000557	0.00142	CcSEcCtD
Oseltamivir—Infection—Doxorubicin—thyroid cancer	0.000553	0.00141	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000548	0.00139	CcSEcCtD
Oseltamivir—Nervous system disorder—Doxorubicin—thyroid cancer	0.000546	0.00139	CcSEcCtD
Oseltamivir—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000545	0.00139	CcSEcCtD
Oseltamivir—Insomnia—Epirubicin—thyroid cancer	0.000544	0.00138	CcSEcCtD
Oseltamivir—Skin disorder—Doxorubicin—thyroid cancer	0.000541	0.00137	CcSEcCtD
Oseltamivir—Dyspepsia—Epirubicin—thyroid cancer	0.00053	0.00135	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00052	0.00132	CcSEcCtD
Oseltamivir—Fatigue—Epirubicin—thyroid cancer	0.000519	0.00132	CcSEcCtD
Oseltamivir—Pain—Epirubicin—thyroid cancer	0.000515	0.00131	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000507	0.00129	CcSEcCtD
Oseltamivir—Insomnia—Doxorubicin—thyroid cancer	0.000504	0.00128	CcSEcCtD
Oseltamivir—Feeling abnormal—Epirubicin—thyroid cancer	0.000496	0.00126	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000492	0.00125	CcSEcCtD
Oseltamivir—Dyspepsia—Doxorubicin—thyroid cancer	0.00049	0.00125	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000481	0.00122	CcSEcCtD
Oseltamivir—Fatigue—Doxorubicin—thyroid cancer	0.00048	0.00122	CcSEcCtD
Oseltamivir—Urticaria—Epirubicin—thyroid cancer	0.000478	0.00122	CcSEcCtD
Oseltamivir—Pain—Doxorubicin—thyroid cancer	0.000476	0.00121	CcSEcCtD
Oseltamivir—Body temperature increased—Epirubicin—thyroid cancer	0.000476	0.00121	CcSEcCtD
Oseltamivir—Abdominal pain—Epirubicin—thyroid cancer	0.000476	0.00121	CcSEcCtD
Oseltamivir—Feeling abnormal—Doxorubicin—thyroid cancer	0.000459	0.00117	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000455	0.00116	CcSEcCtD
Oseltamivir—Hypersensitivity—Epirubicin—thyroid cancer	0.000443	0.00113	CcSEcCtD
Oseltamivir—Urticaria—Doxorubicin—thyroid cancer	0.000442	0.00112	CcSEcCtD
Oseltamivir—Body temperature increased—Doxorubicin—thyroid cancer	0.00044	0.00112	CcSEcCtD
Oseltamivir—Abdominal pain—Doxorubicin—thyroid cancer	0.00044	0.00112	CcSEcCtD
Oseltamivir—Asthenia—Epirubicin—thyroid cancer	0.000432	0.0011	CcSEcCtD
Oseltamivir—Diarrhoea—Epirubicin—thyroid cancer	0.000412	0.00105	CcSEcCtD
Oseltamivir—Hypersensitivity—Doxorubicin—thyroid cancer	0.00041	0.00104	CcSEcCtD
Oseltamivir—Asthenia—Doxorubicin—thyroid cancer	0.0004	0.00102	CcSEcCtD
Oseltamivir—Dizziness—Epirubicin—thyroid cancer	0.000398	0.00101	CcSEcCtD
Oseltamivir—Vomiting—Epirubicin—thyroid cancer	0.000383	0.000973	CcSEcCtD
Oseltamivir—Diarrhoea—Doxorubicin—thyroid cancer	0.000381	0.000968	CcSEcCtD
Oseltamivir—Rash—Epirubicin—thyroid cancer	0.000379	0.000964	CcSEcCtD
Oseltamivir—Dermatitis—Epirubicin—thyroid cancer	0.000379	0.000964	CcSEcCtD
Oseltamivir—Headache—Epirubicin—thyroid cancer	0.000377	0.000958	CcSEcCtD
Oseltamivir—Dizziness—Doxorubicin—thyroid cancer	0.000368	0.000936	CcSEcCtD
Oseltamivir—Nausea—Epirubicin—thyroid cancer	0.000357	0.000909	CcSEcCtD
Oseltamivir—Vomiting—Doxorubicin—thyroid cancer	0.000354	0.0009	CcSEcCtD
Oseltamivir—Rash—Doxorubicin—thyroid cancer	0.000351	0.000892	CcSEcCtD
Oseltamivir—Dermatitis—Doxorubicin—thyroid cancer	0.000351	0.000892	CcSEcCtD
Oseltamivir—Headache—Doxorubicin—thyroid cancer	0.000349	0.000887	CcSEcCtD
Oseltamivir—Nausea—Doxorubicin—thyroid cancer	0.000331	0.000841	CcSEcCtD
